LIFE TECHNOLOGIES CORPORATION | 54,70 Euro | -2,374 -4,16 % | |
| WKN: A0RDDT ISIN: US53217V1098 Ticker-Symbol: IVN | Frankfurt | 21.05.13 | 08:12 Uhr |
Branche BiotechnologieAktienmarkt NASDAQ-100S&P 500 NASDAQ Biotech |
|
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 00:55 | Roche, Sigma teamed up for failed Life Technologies bid -sources | - | Reuters.com | |
| 00:43 | Roche, Sigma teamed up for failed Life Technologies bid: sources | - | Reuters.com | |
| 21.05. | Downgrade Alert for Life Technologies | 2 | SmarTrend | |
| 20.05. | Life Technologies Announces Regulatory Approval of its 3500 Dx Series Genetic Analyzers in Canada | 1 | CNX Marketlink | |
| 16.05. | Zacks Industry Outlook Highlights: Life Technologies, Thermo Fisher Scientific, Bayer, Conceptus and Becton, Dickinson and Co. | 74 | PR Newswire | |
| CHICAGO, May 16, 2013 /PRNewswire/ --Today, Zacks Equity Research discusses the U.S. Medical Technologies, including Life Technologies Corporation (Nasdaq:LIFE), Thermo Fisher Scientific (NYSE:TMO)... Mehr lesen zu: Zacks Industry Outlook Highlights: Life Technologies, Thermo Fisher Scientific, Bayer, Conceptus and Becton, Dickinson and Co. | ||||
| 13.05. | Patent Protection for TAL Effector Technology Enables Licensing Path for Life Technologies Customers | 50 | PR Newswire | |
| CARLSBAD, Calif., May 13, 2013 /PRNewswire/ --Life Technologies Corporation (NASDAQ: LIFE) announced today the issuance of a new patent covering nucleic acids encoding Transcription Activator-Like... Mehr lesen zu: Patent Protection for TAL Effector Technology Enables Licensing Path for Life Technologies Customers | ||||
| 09.05. | Life Technologies steps in as Elan vacates 205,000 square feet at Oyster Point | 4 | bizjournals | |
| 08.05. | The Deal: Thermo Fisher's Purchase of Life Technologies Runs Through China | 5 | The Street | |
| 07.05. | Downgrade Alert for Life Technologies | 4 | SmarTrend | |
| 03.05. | Life Technologies Q1 Profit Down | 80 | AFX News | |
| CARLSBAD (dpa-AFX) - Life Technologies Corp. (LIFE) Thursday reported
first-quarter net income attributable to controlling interest of $121.1 million
or $0.69 per share, compared to $132.6... Mehr lesen zu: Life Technologies Q1 Profit Down | ||||
| 02.05. | Life Technologies Corp - 8-K, Current Report | 1 | SEC Filings | |
| 02.05. | Life Technologies Announces First Quarter 2013 Results | 49 | PR Newswire | |
| CARLSBAD, Calif., May 2, 2013 /PRNewswire/ --Life Technologies Corporation (NASDAQ: LIFE) today announced results for its first quarter ended March 31, 2013. Revenue for the first quarter was $963... Mehr lesen zu: Life Technologies Announces First Quarter 2013 Results | ||||
| 01.05. | Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers / Top Pharma Companies Sitting on Large Amount of Cash Could Fuel Activity in the Months Ahead Burrill & Company Says | 89 | Marketwired | |
| SAN FRANCISCO, CA -- (Marketwired) -- 05/01/13 -- Global M&A activity in the life sciences sector continues to lag the pace of 2012, but signs point to activity increasing as the largest pharmaceutical... Mehr lesen zu: Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers / Top Pharma Companies Sitting on Large Amount of Cash Could Fuel Activity in the Months Ahead Burrill & Company Says | ||||
| 30.04. | Tiangen, Qiagen and Life Technologies Emerge as Leading Suppliers in Chinese Nucleic Acid Purification Market According to Percepta | 64 | Business Wire | |
| However, many second tier suppliers exist, illuminating a markedly different competitive landscape in China in comparison to less fragmented US and Europe markets Percepta Associates... Mehr lesen zu: Tiangen, Qiagen and Life Technologies Emerge as Leading Suppliers in Chinese Nucleic Acid Purification Market According to Percepta | ||||
| 26.04. | Life Technologies Supports Global Effort to Help Accelerate Emergency Screening of Avian Influenza (H7N9) Virus | 28 | PR Newswire | |
| CARLSBAD, Calif., April 26, 2013 /PRNewswire/ --Life Technologies Corporation (NASDAQ: LIFE) today announced that its Applied Biosystems® 7500 Fast Dx Real-Time PCR instrument is the sole platform... Mehr lesen zu: Life Technologies Supports Global Effort to Help Accelerate Emergency Screening of Avian Influenza (H7N9) Virus | ||||
| 25.04. | Life Technologies Investor Sues Over Thermo Fisher Deal | 17 | Bloomberg | |
| 24.04. | Life Technologies Corp - 8-K, Departure of Directors or Certain Officers; Election of Directors; ... | 4 | SEC Filings | |
| 24.04. | Shares of Life Technologies Rise to a New 52-Week High | - | SmarTrend | |
| 23.04. | Life Technologies' Ion Proton(TM) unterstützt Stratified Medicine Scotland Innovation Centre | 78 | news aktuell | |
| - Ehrgeiziger Behandlungsansatz des Innovation Centre soll Behandlungsergebnisse deutlich verbessern und Gesamtkosten für das Gesundheitswesen reduzieren. Glasgow, Schottland (ots/PRNewswire) -... Mehr lesen zu: Life Technologies' Ion Proton(TM) unterstützt Stratified Medicine Scotland Innovation Centre | ||||
| 23.04. | Life Technologies' Ion Proton™ to Power Stratified Medicine Scotland Innovation Centre | - | CNX Marketlink | |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| AMGEN | 79,97 | +0,88 % | Amgen: Kaufen - Ausbruch aus der Flaggenformation gelungen ! |
| QIAGEN | 14,515 | +0,38 % | Qiagen und SYGNIS Pharma schließen Lizenzvertrag |
| MORPHOSYS | 35,82 | +1,62 % | MorphoSys AG: Veröffentlichung gem. § 26 Abs.1 WpHG mit dem Ziel der europaweiten Verbreitung |
| BIOGEN IDEC | 180,00 | +0,90 % | Biogen Idec Submits BLA To FDA For Approval Of Plegridy In Multiple Sclerosis |
| BB BIOTECH | 97,10 | -0,92 % | XFRA H MISTRADE ANTRAG IN ISIN CH0038389992 WURDE STATTGEGEBEN |
